Researchers say ‘the Unicorn,’ their invention at the University of Texas Health Science Center, is a game-changer in the ...
Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...
A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...
The European Union's drugs regulator reversed its decision to block the Alzheimer's drug lecanemab, a treatment aimed at ...
WOOD Grand Rapids on MSN2h
Free memory screenings aim to ‘shed light’ on dementiaA nonprofit assisting dementia patients and their families gave out free memory screenings in southeast Grand Rapids Thursday ...
A key regulatory committee sided against the drug this summer. But an appeal from Eisai appears to have worked, teeing ...
SEC adopts EDGAR Next - As outlined in this October 22 Cooley alert, the Securities and Exchange Commission (SEC) adopted final ...
The European Union's drugs regulator on Thursday recommended approval of Eisai and Biogen's Leqembi for some patients with ...
Along with an Alzheimer’s diagnosis comes a flood of questions, both for the person with the disease and their family. The uncertainty of a future with Alzheimer’s is ...
The AD risk factors/hits include high exposure to traffic-related air pollution (TRAP) and infections, as well as factors ...
Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...
Upon reexamination, the European Medicines Agency has made a U-turn on Eisai and Biogen’s Alzheimer’s disease drug Leqembi. | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback